Most patients who come to KDI Health in Frisco, TX have heard of ketamine therapy, but far fewer know that there is more than one way to administer it — and that the difference between intravenous (IV) and intramuscular (IM) delivery is clinically meaningful.
At our clinic, we offer both IV ketamine treatment and IM ketamine therapy under the direct supervision of Dr. Stephen Gasper. Both approaches may be used off-label for psychiatric conditions such as depression, anxiety, PTSD, and OCD, and both require careful screening, monitoring, and follow-up. IV ketamine remains the more extensively studied route for treatment-resistant depression and some pain applications, while IM ketamine has a smaller but meaningful evidence base.
One of the first clinical conversations we have with new patients is about which method best fits their individual clinical picture, their history, and their goals — because one size does not fit every patient.
Why the Delivery Method Matters
Ketamine can be delivered to the body in several ways, but for psychiatric and chronic pain applications in a supervised clinical setting, IV and IM are two of the main routes used at dedicated ketamine clinics.
The route matters because it affects how ketamine enters the bloodstream, how quickly effects begin, how much control the physician has during the session, and what the treatment experience may feel like for the patient. The right route is not simply the one that sounds easier on paper. It depends on your symptoms, medical history, previous treatment response, venous access, anxiety around needles, practical concerns, and the clinical goals we are trying to support.
For patients comparing options for treatment-resistant depression specifically, our overview of IV ketamine for treatment-resistant depression may be a helpful companion to this discussion.
How IV Ketamine Gives the Physician More Control
With IV ketamine, the medication is delivered directly into the bloodstream through a catheter placed in a vein, typically in the arm or hand. This gives the physician precise control over the rate of delivery during the session.
That control is one of the main reasons IV ketamine has become the most studied route in the depression literature. The onset of effects is rapid, often beginning within minutes of the infusion starting, and the pace of delivery can be adjusted during treatment when clinically appropriate. If a patient is responding more intensely than expected, or if the experience needs to be slowed, the infusion format gives us more flexibility than a fixed-dose injection.
This does not mean IV is automatically the right choice for every person. It does mean that IV ketamine may be especially useful when we want finer control over dose and timing, particularly for patients with complex psychiatric or chronic pain histories.
How IM Ketamine Differs from an Infusion
IM ketamine is delivered by injection into a muscle, often the deltoid or gluteal muscle. From there, the medication is absorbed into the bloodstream over time.
Because the dose is given as an injection rather than an adjustable infusion, the physician cannot change the delivery rate once that dose has been administered. That is an important clinical distinction. IM ketamine can still be an appropriate option for some patients, but it has a different pharmacokinetic profile and a different session experience than IV ketamine.
For patients who want to understand the IM approach in more detail, we have also written about IM ketamine therapy in Frisco, TX and how it fits within our physician-supervised model of care.
Like IV ketamine for psychiatric indications, IM ketamine is used off-label for depression and related mental health conditions. It is not FDA-approved for depression, anxiety, PTSD, OCD, bipolar disorder, or other psychiatric diagnoses. We believe patients deserve that clarity before they make a treatment decision.
How We Help Patients Choose at KDI Health
At KDI Health, we approach the choice between IV and IM as a clinical decision rather than a logistical one.
Several factors inform that conversation. Some patients have a history of difficult IV access, rolling veins, prior medical procedures, or anxiety around catheter placement. For those patients, IM ketamine may feel more practical and less stressful.
Other patients may benefit from the added precision of IV delivery. This can matter for people with complex treatment histories, significant anxiety about the dissociative experience, chronic pain considerations, or prior ketamine exposure where dose control is especially important.
Some patients come to us after trying one approach elsewhere and already have a sense of what felt helpful or difficult. We take that history seriously, but we do not assume it tells the whole story. A prior experience is one piece of the clinical picture, not the entire decision.
What the Treatment Experience May Feel Like
The experiential quality of IV and IM ketamine can differ.
IV infusions allow incremental delivery, which can make the session feel more gradual and controlled. For patients who are worried about dissociation, that controllability can be reassuring. We can monitor how the experience is unfolding and adjust the infusion when clinically appropriate.
IM ketamine is a fixed-dose injection. Because the dose is administered all at once, the experience may feel more abrupt for some patients once the medication begins to take effect. Other patients may prefer the simplicity of the injection and the absence of an IV catheter.
Neither experience is inherently better or worse. The question is which experience is most appropriate for the patient sitting in front of us.
Monitoring, Recovery, and Safety Expectations
From a practical standpoint, IM sessions are often somewhat shorter in chair time than IV infusions because there is no IV line to place and the medication delivery itself takes only a moment. However, both methods require medical monitoring and a post-treatment observation period.
At our clinic, every patient receives physician-supervised care during treatment. We do not treat ketamine as a self-directed process, and we do not make the delivery method less medically serious simply because one route may be faster to administer than another.
Patients should also expect to arrange transportation after treatment. Ketamine can temporarily affect perception, coordination, and alertness, so patients should not plan to drive themselves home after either IV or IM ketamine.
Cost, Insurance, and Practical Fit
Cost considerations sometimes drive questions about IM versus IV, and we want to address that directly.
Neither IV nor IM ketamine for psychiatric indications is typically covered by standard commercial health insurance plans because these are off-label uses. We encourage patients who have concerns about cost to talk with our team about financing options before making a treatment decision based solely on price.
Cost matters. We understand that. But the goal is to choose the right approach clinically, not simply default to the method that seems more economical before your history has been reviewed.
Needle Anxiety and Difficult IV Access
Fear of needles is a common reason patients ask about alternatives, and we take that seriously.
Both IV and IM ketamine involve a needle. IV treatment requires placement of a catheter in a vein, while IM treatment involves a quick injection into muscle. Some patients find IM easier because the needle exposure is brief. Others prefer IV once the line is placed because the experience can be adjusted more gradually.
Dr. Gasper’s background as an emergency physician gives him deep experience with IV placement and procedural comfort. For patients with difficult access or significant anxiety, we talk through the options candidly and decide together whether IV or IM is the better starting point.
Why We Do Not Treat Ketamine as an At-Home Process
Some patients ask whether ketamine can be used outside a clinical setting. At KDI Health, we administer ketamine in a supervised clinical environment because screening, dosing, monitoring, and recovery observation matter.
Ketamine can affect perception, blood pressure, coordination, and emotional state during treatment. We believe those effects should be managed in a setting where a physician-supervised team can respond if the patient needs support.
This is part of why the delivery-method conversation matters. Whether IV or IM is chosen, the treatment is still a medical procedure that deserves preparation, monitoring, and clear post-treatment instructions. You can learn more about what to expect by reviewing our Ketamine Therapy FAQs.
The Right Choice Is Individual
Ultimately, our goal is not to steer patients toward one method or the other based on convenience. Our goal is to make a clinically reasoned recommendation that accounts for your health history, symptom profile, treatment history, and practical circumstances.
Results vary by individual. Part of what that means in practice is that the delivery method that works well for one patient may not be the best starting point for another.
The best way to determine which approach makes sense for you is a consultation where your full history can be reviewed. Patients interested in learning more can schedule a consultation with our team at KDI Health in Frisco, TX.
Frequently Asked Questions
Is IM ketamine as effective as IV ketamine for depression?
Both IM and IV ketamine have evidence supporting their use for treatment-resistant depression in an off-label setting. IV remains the more extensively studied method, but IM ketamine has shown meaningful antidepressant effects in clinical literature as well. The best approach depends on the individual patient and should be determined through a clinical consultation rather than a general comparison.
Can I switch from IM to IV ketamine partway through a treatment series?
This is a clinical question best answered by Dr. Gasper in the context of your specific treatment history and response. Switching methods may be discussed when a patient’s initial response, tolerability, or practical experience suggests that a different protocol could be a better fit. We address these questions on a case-by-case basis.
Does IM ketamine hurt more than IV?
Both methods involve a needle. IM ketamine is a quick intramuscular injection, while IV ketamine involves catheter placement in a vein. Some patients find IM more comfortable because it is brief. Others prefer IV once the catheter is placed because the session can be adjusted more gradually. Comfort depends on the patient, the clinical situation, and the treatment plan.
How long does an IM ketamine session take compared to IV?
IM sessions are often somewhat shorter in chair time because there is no IV line to place and the medication delivery is nearly immediate. However, patients should still expect monitoring and recovery time regardless of delivery method. We will explain the expected timing for your specific protocol before treatment begins.
Which method should I choose if I am anxious about dissociation?
Anxiety about the dissociative experience is common, and it is one of the reasons we talk carefully about delivery method before treatment begins. Some patients feel reassured by the adjustability of IV treatment. Others feel more comfortable with the simplicity of an IM injection. We do not expect you to know the right answer before your consultation. That decision should be made with a clinician who understands your history.
Key Takeaways
- IV ketamine allows more precise real-time control over delivery, while IM ketamine is a fixed-dose intramuscular injection.
- Both IV and IM ketamine are used off-label for psychiatric conditions at KDI Health.
- IV ketamine is the more extensively studied route, but IM ketamine has a meaningful and growing evidence base.
- The choice between IV and IM should be a clinical decision made with Dr. Gasper, not primarily driven by convenience or cost.
- Both methods require medical supervision, monitoring, and post-session recovery time.
- Patients with difficult IV access, needle anxiety, specific experiential preferences, or complex clinical histories may be better suited to one approach over the other.
Conclusion
Choosing between IV and IM ketamine is not a decision that should be made by reading a comparison article alone. It is a conversation that requires a clinician who knows your history.
At KDI Health in Frisco, TX, that conversation happens during your consultation with Dr. Gasper. We take it seriously because the route of administration is not just a technical detail. It shapes the clinical control, patient experience, and treatment planning process.
If you are considering ketamine therapy and want to understand which approach may be right for you, we invite you to schedule a consultation with our team.
About Dr. Stephen Gasper
Dr. Stephen Gasper is the owner and medical director of KDI Health Ketamine Clinic, which he founded in early 2021 in Frisco, TX. At the age of 17, he enlisted in the Marines, serving four years as a forward observer in the infantry. He then moved to Texas and obtained his BS in Biology from the University of Dallas.
Dr. Gasper received his Medical Degree from UTHealth Houston in 2011 and practiced medicine in the DFW area for more than 10 years as a board-certified emergency physician. He was inspired to found KDI Health during the COVID pandemic because of the effectiveness of ketamine as a therapy adjunct for veterans and the broader community struggling with depression, anxiety, and PTSD.
At KDI Health, Dr. Gasper personally oversees ketamine treatment and provides direct physician involvement throughout the care process.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether ketamine therapy is appropriate for your specific medical and mental health history.
Works Cited
Ahuja, S., Cole, R., Gnirss, M., & McCormick, Z. L. (2022). Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: A retrospective descriptive cohort study. Journal of Psychopharmacology, 36(12), 1355–1364.
Chilukuri, H., Reddy, N. P., Pathapati, R. M., Manu, A. N., Jollu, S., & Shaik, A. B. (2014). Acute antidepressant effects of intramuscular versus intravenous ketamine. Indian Journal of Psychological Medicine, 36(1), 71–76.
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982). Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. Journal of Pharmaceutical Sciences, 71(5), 539–542.
Loo, C. K., Gálvez, V., O’Keefe, E., Mitchell, P. B., Hadzi-Pavlovic, D., Leyden, J., Harper, S., Somogyi, A. A., Lai, R., Weickert, C. S., & Glue, P. (2016). Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatrica Scandinavica, 134(1), 48–56.
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., & Nemeroff, C. B. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405.
Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A. (2022). Ketamine treatment for depression: A review. Discover Mental Health, 2, 9.
